Take-Private Transaction Announced
Agreement to be acquired for $16.50 per share; unanimously approved by the Board; expected close mid-2026 (subject to approvals). Hart-Scott-Rodino waiting period expired Apr 27, 2026. Upon closing, company will become privately held and senior secured credit facilities will provide an additional $1.0B term loan at interest = SOFR + 3%.
Consolidated Revenue Growth
Total revenue increased 5% year-over-year across all three operating divisions.
Inpatient Rehabilitation Segment Outperformance
Inpatient rehab revenue rose >14% y/y to ~$351.9M and adjusted EBITDA increased 15% to $81.1M. Revenue per patient day increased ~3%, average daily census grew 12%, occupancy increased to 83% (from 82%), same-store occupancy to 87% (from 83%); adjusted EBITDA margin modestly improved to 23% from 22.9%.
Development Pipeline Expansion
Added 166 beds across 3 newly opened inpatient rehab hospitals year-to-date. Expect to add 275 more beds (209 IRF and 66 critical illness) across 2026–2027, including specific openings (60-bed AtlantiCare, 76-bed Jersey City, multiple acute rehab and neuro units) and further Banner expansion (+20 beds).
Outpatient Revenue and Volume Growth
Outpatient revenue grew >4% y/y to $321.3M driven by >4% growth in patient visits. Net revenue per visit remained flat at $102.
Regulatory Payment Proposals Favorable
CMS proposed FY2027 rules: IRF standard federal payment rate expected to increase ~2.6% and LTACH standard federal payment rate expected to increase ~2.66% (high-cost outlier threshold steady at $78,936), which would be modest tailwinds if finalized.
Maintained Full-Year Guidance and Capital Plan
Management maintained 2026 guidance: revenue $5.6B–$5.8B, adjusted EBITDA $520M–$540M, diluted EPS $1.22–$1.32, and capital expenditures $200M–$220M. Board approved a cash dividend of $0.0625 per share payable May 28, 2026.
Stable Interest Expense and Liquidity Availability
Interest expense modestly decreased to $28.3M from $29.1M y/y. Ended quarter with $443.5M availability on revolver and net leverage of 3.75x under credit agreements.